Replies to post #251254 on Biotech Values

[Mufaso]

VK2735 has specific liver fat reduction properties that are promising. See #msg-173042423. Time will tell if it also has an a "clinically meaningful" effect on fibrosis like the dual GLP1-GIP agonist trizepatide which does not exist as an oral.

Picking any small molecule GLP1 is not likely to be as effective.